• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

EXENATIDE

Diabetes drugs for Alzheimer’s disease

September 5, 2018Metabolic Disorders, Nervous System Disorders, Vizit Graphs
Diabetes drugs for Alzheimer’s disease

Repurposing Diabetes drugs for Alzheimer’s disease. View pathways associated with the action of Exenatide in Alzheimer’s.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

IMMUNE RESPONSE ERBB-2 IFNG IL6 CD4 TNF ALZHEIMER'S DISEASE CELL DEATH IL17A INFLAMMATION DOXORUBICIN CLOSTRIDIUM DIFFICILE RHEUMATOID ARTHRITIS APOPTOTIC PROCESS TH17 CELLS IL23A AUTOPHAGY ANGIOGENESIS CANCER STREPTOCOCCUS PNEUMONIAE DIABETES MELLITUS BREAST CANCER INSULIN CTLA4 STAPHYLOCOCCUS AUREUS CELL PROLIFERATION 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE REMICADE HELICOBACTER PYLORI CELL DIFFERENTIATION SOD1 CELL DIVISION PSEUDOMONAS AERUGINOSA RECEPTOR LISTERIA MONOCYTOGENES FOXP3 AGING ESCHERICHIA COLI PARKINSON DISEASE NEURODEGENERATIVE DISORDERS CANDIDA ALBICANS CASP3 TP53 PORPHYROMONAS GINGIVALIS METFORMIN

© 2019 Biovista Vizit All Rights Reserved.